ToolGen Incorporated (KOSDAQ:199800)

Market Cap	276.29B
Revenue (ttm)	890.96M
Net Income (ttm)	6.23B
Shares Out	8.55M
EPS (ttm)	776.00
PE Ratio	41.62
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,162
Average Volume	26,443
Open	32,950
Previous Close	33,000
Day's Range	31,700 - 32,950
52-Week Range	30,050 - 89,900
Beta	1.75
RSI	34.29
Earnings Date	Mar 21, 2025

About ToolGen

ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1999
• Employees: 84
• Stock Exchange: KOSDAQ
• Ticker Symbol: 199800

Financial Performance

In 2023, ToolGen's revenue was 1.10 billion, an increase of 48.41% compared to the previous year's 743.46 million. Losses were -42.34 billion, 132.9% more than in 2022.